Delivery Order SPE2DB25D3109-SPE2DB25FPKKY

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,721.57 firm fixed-price delivery order is for the supply of 4,566,708,164 units of Methyldopa 250 mg tablets, with a period of performance through December 13, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,408.11 firm fixed-price delivery order is for the supply of 4566161818 - Methyldopa 250 mg Tablets in 90-count packages. The award has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This federal contract award, with ID SPE2DB25D3504|SPE2DB25FVUHS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,145.47 delivery order contract is for the supply of 4,567,958,207 tablets of the medication Methyldopa 250 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp also holds a significant...
This federal contract award, valued at $1,349.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,038,863 tablets of Methyldopa 250 mg, a medication used to treat high blood pressure. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor, and there...
This federal contract award is for the delivery of 180 tablets of 250 mg methyldopa, a drug used to treat high blood pressure. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 26, 2025. The contract has a ceiling value of $1,551.10 and runs through March 27, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565213357 Methyldopa 250 mg tablets in 90-count packages. The contract has a firm fixed price of $1,128.47 and a period of performance through July 22, 2024. It is not a set-aside contract. As a large pharmaceutical vendor, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,231.25 firm fixed-price delivery order is for the supply of 4,568,235,107 units of the medication Methazolamide 50 mg tablets. The award is not set-aside and has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,498.80 firm fixed-price delivery order is for the supply of 4,567,972,776 units of the medication methylergonovine 0.2 mg tablet in 20-count units. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 19, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,529.68 firm fixed-price delivery order is for the supply of Methazolamide 25 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPKKY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,167.06 firm-fixed-price delivery order is for the supply of 4,568,250,671 units of the drug Methyldopa 250 mg Tablet, with a performance period extending through May 15, 2025.

Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 8/13/25, 10:59 AM